Cauda Equina Syndrome
Suspected cauda equina compression is a spinal emergency. New sacral symptoms (altered bladder or bowel function, perineal sensation, or sexual function) warrant urgent assessment for cauda equina compression. Back or leg pain can be absent; obtain emergency MRI when CES is suspected (within four hours of the radiology request in the NHS GIRFT pathway).[11][13] Do not wait for complete retention or every feature of the classic syndrome, and do not delay imaging for urodynamics. Confirmed compressive disease requires prompt specialist decisions about decompression as soon as safely feasible.[1]
Drain clinically important retention while arranging spinal care. Record symptoms, neurological findings and bladder volume. Subsequent neuro-urological care depends on recovery and measured lower urinary tract function.
Recognition and timing
CES is most often caused by a large central lumbar disc herniation, less often by tumor, trauma, epidural abscess or hematoma. Typical features are low back pain with bilateral sciatica, saddle (perineal) numbness, new urinary retention or incontinence, bowel incontinence or reduced anal tone, and sexual dysfunction.[5][6] Across 18 studies of adults with suspected CES, 19% met both clinical and radiological criteria for CES; published definitions vary widely.[5][6]
Two working categories guide counseling:
- CES-I (incomplete): altered urinary sensation, reduced desire to void, poor stream or straining, but still voluntary voiding.
- CES-R (retention): painless retention with overflow, and usually loss of bladder sensation.
Timing evidence is observational. A 2026 meta-analysis of 15 comparative studies involving 26,627 adults decompressed for degenerative CES found that, in clinical cohorts, surgery within 48 hours of symptom onset was associated with better early urinary recovery (pooled OR about 2.3) and neurological outcomes than later surgery; the timing signal was strongest in incomplete CES.[6] Retention-type CES showed no significant timing difference, surgery inside 24 hours was not consistently better than 24–48 hours, and at 12 months or more baseline bladder status was the dominant prognostic factor.[6] Expedite MRI for both CES-I and CES-R, and decompress confirmed compressive CES as soon as safely feasible; for CES due to a large disc prolapse, the NHS GIRFT 2026 pathway calls for immediate spinal-surgery referral, CES-I surgery as quickly as possible, and CES-R surgery within 24 hours of MRI.[13] For retention-type CES, counsel that bladder recovery remains uncertain even after prompt decompression.[1][6]
Urology's role in the acute phase:
- Catheterize for retention and record the drained volume and perineal or anal findings. In patients who void, document PVR; a PVR <200 mL does not exclude CES and must not delay emergency MRI when suspicion persists.[12]
- Do not delay MRI or neurosurgical referral for urological testing.
- In suspected CES, obtain emergency MRI; after compression is confirmed, refer immediately to spinal surgery without waiting for urodynamics.[13] In selected cases with equivocal neurovesical findings, multichannel urodynamics may clarify involvement: a retrospective series of 245 MRI-positive referrals used uroflowmetry/PVR screening and invasive urodynamics in 211 patients, attributing neurovesical involvement to compression in 141 (57.6%).[7]
Bladder phenotype after the acute event
Root-level (sacral or infrasacral) injury classically gives an underactive or acontractile detrusor, a denervated or low-tone external sphincter, reduced sensation and weak outlet resistance. Typical patterns include:
| Feature | Typical pattern | Caveat |
|---|---|---|
| Detrusor | Underactive or acontractile | Detrusor overactivity in 20 of 61 patients with CES and neurogenic bladder (32.8%) in a urodynamic series, most with electrophysiological injury at L2 or above (possible conus involvement)[2] |
| External sphincter | Denervated, EMG shows denervation | Sphincter EMG and pelvic neurophysiology help when sacral root involvement is in doubt[4] |
| Storage pressure | Usually low | Poor compliance can develop later; surveillance follows the measured NLUTD risk category[3] |
| Outlet | Weak, stress leakage and overflow | Variable; some bladder necks remain competent |
| Sensation | Reduced or absent | Bladder fullness may go unrecognized |
Assess storage pressure and compliance, emptying and outlet competence separately. Symptoms and MRI level do not reliably predict bladder type, so use urodynamics before planning irreversible treatment.[2]
Outcomes
Recovery is often incomplete. In a 2026 meta-analysis of 16 observational studies of surgically decompressed degenerative CES, pooled persistent bladder dysfunction at 12 months or later was 32.6% (95% CI 23.4–41.9%; marked heterogeneity) among 987 patients across study-defined urinary outcomes.[8] Among those with preoperative dysfunction and paired data, 130/278 (46.8%) had persistent dysfunction.[8] Retention at presentation predicted worse recovery.[8] Reassess bladder recovery and storage safety over time; for low compliance or refractory neurogenic detrusor overactivity, EAU 2026 strongly recommends augmentation after less-invasive treatment fails.[4]
Evaluation and follow-up
- After neurological stabilization: assess urinary symptoms and PVR in patients who void. If NLUTD risk remains unknown, obtain renal function assessment, upper-tract ultrasound and multichannel (ideally video) urodynamics to document detrusor function, compliance, outlet competence and reflux. Reassess earlier for retention, infection or renal findings.[3]
- Surveillance: follow the NLUTD risk category, with earlier review for clinical change. Do not obtain routine urine cultures or treat asymptomatic bacteriuria outside a recognized exception.[3]
Management
Emptying. Intermittent catheterization is the mainstay when hand function and anatomy allow; AUA/SUFU recommends it over indwelling catheters .[3] Avoid habitual Credé or Valsalva unless urodynamics show safe intravesical pressures and effective emptying; both can raise outlet resistance and worsen stress leakage.[3][4] The NHS England GIRFT pathway (updated March 2026) advises a trial without catheter as soon as possible after surgery, with pre- and post-void bladder scans. After a failed trial, the pathway calls for recatheterization without an immediate repeat trial, prompt intermittent self-catheterization teaching when feasible, and spinal cord injury or urology follow-up.[13] A flip-flow catheter should be opened at least every four hours, including overnight, to keep bladder volume <500 mL; patients should empty by schedule rather than urge.[13] When intermittent catheterization is infeasible, discuss long-term drainage; AUA/SUFU strongly recommends suprapubic over urethral catheterization for appropriately selected patients who need a chronic indwelling catheter.[3] A small 2025 series of 40 patients with CES-related bladder dysfunction reported better urodynamic and quality-of-life results with intermittent catheterization plus TENS than with indwelling catheterization plus TENS.[9]
Storage and continence. Treat the dysfunction that is demonstrated.
| Option | Role in CES |
|---|---|
| Pelvic-floor training, alpha-agonists | Limited benefit with denervation |
| Antimuscarinic or beta-3 agonist | EAU 2026 strongly recommends either for neurogenic overactive-bladder symptoms and strongly recommends against beta-3 agonists to reduce urodynamically proven neurogenic detrusor overactivity.[4] |
| Bulking agent | Occasional adjunct |
| Sling | Consider for persistent SUI after confirming safe storage and a catheterization plan. AUA/SUFU statement 45 is moderate (Grade C) and advises avoiding synthetic material if future CIC or an occlusive sling is expected; autologous fascia is an option.[3] EAU 2026 strongly recommends autologous sling first-line for self-catheterizing women, with synthetic sling a weak alternative in selected women.[4] |
| Artificial urinary sphincter | Option for neurogenic SUI (AUA/SUFU statement 46, conditional recommendation, Grade C, for selected patients with acceptable storage parameters[3]; EAU 2026: strong recommendation in men, weak and referral to an experienced center in selected women), with higher complication and reoperation rates in neurological patients; requires safe storage, a catheterization plan, and enough hand function to operate the pump[3][4] |
| Sacral neuromodulation | EAU 2026 strongly recommends considering sacral neuromodulation in selected neurological patients.[4] |
| Augmentation, catheterizable channel, bladder-neck closure, diversion | Late options for refractory poor compliance, inaccessible urethra or failed reconstruction; consider augmentation according to measured storage pressure and compliance after less invasive treatment fails[4] |
Choose an outlet procedure only for established SUI with safe bladder storage and a workable catheterization plan.
Bowel and sexual function. Sacral denervation usually affects all three systems, so ask about them together.
- Bowel: fecal incontinence and constipation are common. Tailor a scheduled regimen and stool consistency to reflex function; the SCI bowel guideline recommends manual evacuation for an areflexic pattern (strength C), with fiber or softeners adjusted to stool, transanal irrigation when basic bowel management is insufficient, and MACE for severe SCI-associated neurogenic bowel dysfunction after other modalities have failed.[14]
- Sexual: a 2026 systematic review (5 studies) found long-term sexual dysfunction in 48–67% (pooled 58.4%) of men and women, including arousal, orgasm and satisfaction problems as well as erectile dysfunction. Outcomes track severity of neural compromise more than timing. Manage erectile dysfunction stepwise (PDE5 inhibitor, intracavernosal injection, prosthesis); refer for sperm retrieval when fertility is desired.[10]
See the NLUTD framework, Urodynamics, AUS, Male Urethral Slings, Catheterizable Channels, and Augmentation Cystoplasty for specific evaluations and interventions.
References
1. British Association of Spine Surgeons. Cauda Equina Syndrome; BASS/SBNS standards of care. Accessed September 11, 2026.
2. Kim SY, Kwon HC, Hyun JK. Detrusor overactivity in patients with cauda equina syndrome. Spine. 2014;39:E955–E961. doi:10.1097/BRS.0000000000000410.
3. AUA/SUFU. Adult Neurogenic Lower Urinary Tract Dysfunction Guideline. Approved 2021. Full guideline, statements 6–7, 13–17, 23–24, 35 and 45–46.
4. European Association of Urology. Neuro-urology guideline. 2026 limited update. Guideline, sections 3.3.7.c, 3.4.2.a, 3.4.3 and 3.4.3.b. Accessed September 2026.
5. Hoeritzauer I, Wood M, Copley PC, et al. What is the incidence of cauda equina syndrome? A systematic review. J Neurosurg Spine. 2020;32(6):832-841. doi:10.3171/2019.12.SPINE19839
6. Najjar E, Egu C, Akil H, et al. Reassessing the clock in cauda equina syndrome: a systematic review and meta-analysis of surgical timing and outcomes. Spine J. 2026;26(9):1653-1670. doi:10.1016/j.spinee.2026.04.013
7. Kalidindi KKV, Chhabra HS, Suman D, et al. Cauda equina syndrome: false-positive diagnosis of neurogenic bladder can be reduced by multichannel urodynamic study. Eur Spine J. 2020;29(6):1236-1247. doi:10.1007/s00586-019-06277-7
8. Najjar E, Muscogliati R, Trumble C, et al. Reassessing bladder recovery in cauda equina syndrome: long-term outcomes after surgical decompression: a systematic review and meta-analysis. Spine J. Published online July 21, 2026. doi:10.1016/j.spinee.2026.07.005
9. Wu X, Huang J, Wu D, et al. Efficacy and safety of transcutaneous electrical nerve stimulation combined with clean intermittent catheterization for neurogenic bladder dysfunction in patients with cauda equina syndrome. Int Urol Nephrol. 2025;57(10):3227-3232. doi:10.1007/s11255-025-04515-0
10. Najjar E, Trumble C, Nocun W, et al. Sexual dysfunction after cauda equina syndrome: a systematic review of long-term outcomes. Eur Spine J. Published online July 20, 2026. doi:10.1007/s00586-026-10170-5
11. Vaishya S, Pojskic M, Bedi MS, et al. "Cauda equina, conus medullaris and syndromes mimicking sciatic pain: WFNS spine committee recommendations." World Neurosurg X. 2024;22:100274. doi:10.1016/j.wnsx.2024.100274
12. Boktor J, Wong F, Joseph VM, et al. "Predictive value of post-void residual volume as an adjunctive tool in the clinical evaluation of cauda equina syndrome." Bone Joint J. 2023;105-B(5):487-495. doi:10.1302/0301-620X.105B5.BJJ-2022-0739.R2
13. Getting It Right First Time. "Spinal Surgery: National Suspected Cauda Equina Syndrome (CES) Pathway." NHS England; February 2023, updated March 2026. Official pathway
14. Johns J, Krogh K, Rodriguez GM, et al. "Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers." J Spinal Cord Med. 2021;44(3):442-510. doi:10.1080/10790268.2021.1883385.